博瑞医药股价跌5.27%，长城基金旗下1只基金重仓，持有2.83万股浮亏损失11.05万元

Group 1 - The core point of the news is that Borui Pharmaceutical's stock has experienced a significant decline, dropping 5.27% on September 24, with a cumulative drop of 21.94% over three consecutive days [1][2] - As of the report, Borui Pharmaceutical's stock price is 70.12 yuan per share, with a trading volume of 839 million yuan and a turnover rate of 2.76%, resulting in a total market capitalization of 29.645 billion yuan [1] - Borui Pharmaceutical, established on October 26, 2001, and listed on November 8, 2019, focuses on the research and production of high-end generic drugs and original new drugs [1] Group 2 - Longcheng Fund has a significant holding in Borui Pharmaceutical, with its Longcheng SSE Sci-Tech Innovation Board 100 Index Enhanced A fund holding 28,300 shares, accounting for 1.85% of the fund's net value, making it the ninth-largest holding [2] - The fund has incurred a floating loss of approximately 110,500 yuan today and a total floating loss of 589,500 yuan during the three-day decline [2] - The fund manager, Lei Jun, has been in position for 10 years and 279 days, with the fund's total asset size at 3.443 billion yuan and a best return of 166.88% during his tenure [2]